CVS to Cover Lilly’s GLP-1 Medications, Expanding Access
CVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Choosing the right retirement account at 30 can be challenging. Learn about the different options available to make the best choice for your future.
22,749 articlesCVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
SoFi Technologies jumps after unveiling SoFiUSD, a bank-issued stablecoin with Mastercard settlement integration, fue...
Salesforce just announced a massive buyback, but does that mean now is the time to buy CRM stock? This guide breaks d...
A late-stage study shows an experimental pill nearly doubles median survival for patients with advanced pancreatic ca...
With the CLARITY Act stalled in Congress, experts warn that a full U.S. crypto regulatory framework could slip past 2...
A major move in the ETF world: Security Financial Services opens a substantial CORO stake. This article breaks down w...
Bitcoin tumbles under $70,000 as altcoins take the lead in a volatile session. Bitcoin dominance slips, signaling a s...
Optics stocks jump mid-session as coherent advances 16%, lumentum lift the sector; Applied Optoelectronics also gains...
A fresh look at a chilling historical echo: the 1987 omen: kevin warsh's. As markets brace for a new Fed chair, inves...
Broadcom is slated to report fiscal Q2 results after the market closes today, with investors focusing on AI-driven re...
A niche shipping ETF has delivered extraordinary gains in 2026, turning a $100,000 investment into several million as...
A dramatic May surge can lure investors, but this glorious growth stock may face headwinds in June. This guide explai...